The effects of Gender-Affirming Hormone Therapy (GAHT) on blood pressure of transgender adolescents as measured by ambulatory blood pressure monitoring (ABPM) over the first year of therapy
Brief description of study
The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment of transgender adolescents, in order to provide more comprehensive counsel to patients regarding the possible risks.
Clinical Study Identifier: s23-01455
Principal Investigator:
Marissa Lipton.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.